ROBERT A INGRAM Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT A INGRAM.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT A INGRAM. ROBERT A INGRAM is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in CREE INC ($CREE) and a Director in REGENERON PHARMACEUTICALS INC ($REGN) and a Director in Valeant Pharmaceuticals International, Inc. ($BVF) and a Director in Edwards Lifesciences Corp ($EW) and a Director in Novan, Inc. ($NOVN) and a Director in Black Diamond Therapeutics, Inc. ($BDTX).

Over the past year ROBERT A INGRAM has been an insider in 2 companies. The total value of shares held by ROBERT A INGRAM in these companies amounts to $425,324.

ROBERT A INGRAM Director
Bausch Health Companies Inc.
Director
BIOCRYST PHARMACEUTICALS INC
Director
Black Diamond Therapeutics, Inc.
Director
CREE, INC.
Director
Edwards Lifesciences Corp
Director
Novan, Inc.
Director
REGENERON PHARMACEUTICALS, INC.
$ 425324 The total value of shares held by ROBERT A INGRAM
Insider Rank

ROBERT A INGRAM ranks 19,459 out of 350,000 insiders. Go to Insider Ranking to see more.

Companies in which ROBERT A INGRAM is an Insider

Bausch Health Companies Inc.

Trading Symbol: BVF
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 89,926 shares
Latest Transaction: Jan 04 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 21,060
Shares Sold: 0
Share Difference: +21,060
Value Difference: -$64,230

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 75,013 shares
Current Value: $425,324
Latest Transaction: Mar 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 18x
Sell: 0x
Shares Bought: 84,179
Shares Sold: 0
Share Difference: +84,179
Value Difference: -$312,715

Black Diamond Therapeutics, Inc.

Trading Symbol: BDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT A INGRAM: Director
Holdings: 6,182 shares
Latest Transaction: Mar 22 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 6,182
Shares Sold: 0
Share Difference: +6,182
Value Difference: -$185,856

CREE, INC.

Trading Symbol: CREE
Industry: SEMICONDUCTORS & RELATED DEVICES [3674]
Position of ROBERT A INGRAM: Director
Holdings: 77,710 shares
Current Value: $2,171,217
Latest Transaction: Oct 18 2018
$CREE Market Capitalization: $2.75B
$CREE Previous Close: $27.94

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 14x
Sell: 0x
Shares Bought: 27,771
Shares Sold: 0
Share Difference: +27,771
Value Difference: -$425,992

Edwards Lifesciences Corp

Trading Symbol: EW
Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of ROBERT A INGRAM: Director
Holdings: 32,367 shares
Current Value: $2,936,011
Latest Transaction: May 19 2015
$EW Market Capitalization: $19.41B
$EW Previous Close: $90.71

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Novan, Inc.

Trading Symbol: NOVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 169,777 shares
Current Value: $690,992
Latest Transaction: Jul 30 2020
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 139,777
Shares Sold: 0
Share Difference: +139,777
Value Difference: -$307,309

REGENERON PHARMACEUTICALS, INC.

Trading Symbol: REGN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT A INGRAM: Director
Holdings: 1,500 shares
Current Value: $536,535
Latest Transaction: May 27 2015
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of ROBERT A INGRAM

Sentiment: All, BVF, BCRX, BDTX, CREE, EW, NOVN, REGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 22 2021BDTXBlack Diamond Ther ...INGRAM ROBERT ALEXANDERDirectorGrantA24.0167716,2556,1825.5 K to 6.2 K (+12.30 %)
Mar 02 2021BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA10.781,73918,74675,01373.3 K to 75 K (+2.37 %)
Dec 16 2020BDTXBlack Diamond Ther ...INGRAM ROBERT ALEXANDERDirectorGrantA34.2950517,3165,5055 K to 5.5 K (+10.10 %)
Dec 02 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA5.113,66918,74973,27469.6 K to 73.3 K (+5.27 %)
Oct 01 2020BDTXBlack Diamond Ther ...INGRAM ROBERT ALEXANDERDirectorBuyP30.465,000152,2855,0000 to 5 K
Sep 29 2020BDTXBlack Diamond Ther ...INGRAM ROBERT ALEXANDERDirectorOption ExerciseA29.6529,842884,81529,842
Sep 02 2020BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA4.154,51818,75069,60565.1 K to 69.6 K (+6.94 %)

View all ROBERT A INGRAM insider transactions.